COVID-19 Vaccines Show Promise in Reducing Infection and Transmission

Strategic Insights -

New data from a UK survey suggests that COVID-19 vaccines can significantly reduce infection and transmission rates, with one dose leading to a two-thirds drop in cases and 74% effectiveness against symptomatic infection. The research, conducted by the University of Oxford and the Office for National Statistics, found that after two doses of the Pfizer vaccine, there was a 70% reduction in all cases and a 90% drop in symptomatic cases. The study's chief investigator, Professor Sarah Walker, expressed cautious optimism that vaccines could control the pandemic long term, but emphasized the need for continued adherence to guidelines to reduce transmission risk.

Key Takeaways:

  • One dose of either the Pfizer/BioNTech or AstraZeneca vaccines leads to a two-thirds drop in cases and is 74% effective against symptomatic infection.
  • After two doses of Pfizer, there was a 70% reduction in all cases and a 90% drop in symptomatic cases.
  • Vaccines can reduce transmission and are effective against the Kent variant of coronavirus.
  • The data showed a 57% drop in infections among people not experiencing symptoms after one vaccine dose.
  • The experts were 'fairly confident' that the vaccines reduced onward transmission of the virus.
  • Vaccinated individuals can still get COVID-19 again and transmit the virus, albeit at a lower rate.
  • The virus is 'very good at throwing us curveballs,' and 'we are always going to be one small step away from the potential for things to go wrong again.'

Statistics:

  • One dose of either vaccine leads to a two-thirds drop in cases (around 67% reduction).
  • 74% effectiveness against symptomatic infection.
  • 70% reduction in all cases after two doses of Pfizer.
  • 90% drop in symptomatic cases after two doses of Pfizer.
  • 57% drop in infections among people not experiencing symptoms after one vaccine dose.
  • 373,000 adults from across the UK participated in the national Covid-19 Infection Survey.
  • 1.6 million swab test results were produced between December and April.
  • Vaccines could reduce transmission by up to 90% against symptomatic cases.

Sources:

  • University of Oxford and the Office for National Statistics (ONS)
  • Professor Sarah Walker, University of Oxford, and chief investigator for the survey
  • Dr. Koen Pouwels, senior researcher at Oxford University's Nuffield Department of Population Health